Latest Laboratory Response Network Stories

CDC Report notes advances in preparedness and response and challenges ahead ATLANTA, Sept. 21 /PRNewswire-USNewswire/ -- State and local health departments have made significant progress toward improving public health emergency preparedness and response capabilities, says a Centers for Disease Control and Prevention report. "Today's report indicates that our nation is better prepared to respond to a public health emergency. It also reminds us that preparedness challenges remain and our...

NORTHFIELD, Ill., April 28 /PRNewswire-USNewswire/ -- Long regarded as the gold standard in monitoring medical laboratory performance, the College of American Pathologists (CAP) believes that the nation's laboratories will be able to adequately process and handle influenza cases and adapt to evolving guidelines from the Centers for Disease Control (CDC). Their readiness is demonstrated through the CAP's Proficiency Testing (PT) program. The College's program is the largest laboratory peer...

SILVER SPRING, Md., March 30 /PRNewswire-USNewswire/ -- The Laboratory Response Network (LRN), the national laboratory system charged with protecting the public in health emergencies, will mark its first decade at its national meeting in Orlando, Florida, April 1-3, 2009. Founded in 1999 by the Association of Public Health Laboratories (APHL), the Centers for Disease Control and Prevention (CDC) and the Federal Bureau of Investigation (FBI) to test for agents of bioterrorism, the...

Pilgrim Software, Inc., a world-leading provider of Enterprise Compliance and Quality Management software solutions, today announced the Centers for Disease Control and Prevention (CDC) will implement Pilgrim's automated platform for document control, complaints and corrective and preventive action (CAPA) systems management throughout the Laboratory Response Network (LRN) under the Division of Bioterrorism Preparedness & Response. Pilgrim Software was selected as the provider of the LRN's...

A method for identifying Bacillus anthracis, the causative agent of anthrax, has been cleared for diagnostic use by the U.S. Food and Drug Administration (FDA). The test, known as the Gamma Phage Assay, was modified by scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to improve its performance and reliability when used with clinical specimens. The original form of the Gamma Phage Assay was first developed by the Centers for Disease Control and...